Key Takeaways
- A 2025 systematic review in JMIR mHealth and uHealth found that privacy concerns, complexity, and low digital literacy are the three most cited barriers to IoT device acceptance across healthcare settings.
- A cross-sectional study in Frontiers in Public Health identified distinct eHealth literacy profiles tied to age, education, and income, meaning a single patient-education approach will miss large subgroups.
- Cancer patients in a Journal of Medical Internet Research survey used digital communication tools at widely different rates depending on treatment type, age, and institutional support—pointing to a gap between tool availability and actual use.
- A JMIR Formative Research survey on a wearable fetal heart monitor found high prospective acceptability among pregnant users, but flagged comfort, skin sensitivity, and data-interpretation anxiety as unresolved design problems.
- A mixed-methods protocol from Khyber Pakhtunkhwa, Pakistan, shows that even a well-designed digital emergency referral system faces implementation barriers rooted in infrastructure, training, and clinician buy-in rather than technology itself.
What are the biggest barriers to IoT health adoption according to recent research?
Research on IoT health adoption barriers consistently points to two dominant problems: patients don’t trust the technology with their data, and many simply lack the digital skills to use it. A 2025 systematic review covering patient acceptance of IoT in healthcare identified privacy and security concerns as the single most frequently cited barrier across studies, followed closely by low health technology literacy and poor device usability.
The literacy gap is sharper than most telehealth marketing acknowledges. A cross-sectional study on eHealth literacy found that sociodemographic factors — age, education level, and income — strongly predicted which patients could actually navigate digital health tools. Older adults and lower-income groups clustered into profiles with significantly weaker eHealth literacy scores. This matters. The patients who most need remote monitoring are often the least equipped to use it without hands-on support.
Privacy distrust runs alongside the literacy problem, not separately from it. The IoT systematic review found patients worried specifically about who accesses their health data, how long it is stored, and whether device manufacturers share it with third parties. These aren’t abstract fears. They reflect real gaps in how IoT health companies communicate data practices to consumers.
Cost and infrastructure access compound both issues. The IoT systematic review identified device cost and unreliable internet connectivity as structural barriers that disproportionately affect rural and low-income patients. A survey of cancer patients using digital health tools found that patients without reliable device access or technical support were far less likely to engage with remote monitoring, even when it was offered. A study on a wearable fetal heart monitor found that user acceptability dropped when participants felt they lacked adequate instruction — pointing to a support gap that device makers rarely advertise.
Usability is its own category of failure. Devices designed without input from the intended patient population tend to generate low adoption rates regardless of clinical value. The IoT systematic review specifically called out poor interface design and lack of patient-centered development as recurring adoption obstacles.
Before committing to an IoT health product, ask direct questions. Who owns the data this device collects? What happens to it if the company closes or sells? Is there live technical support, or just a PDF manual?
This section presents general health technology information for educational purposes and does not constitute medical advice. Consult a qualified healthcare professional for guidance specific to your situation.
Who is most likely to be left behind by eHealth tools, and why?
Disclaimer: This section presents general health information for educational purposes only. It is not medical advice, diagnosis, or treatment guidance. Consult a qualified healthcare professional for personal health decisions.
Older adults, people with low digital literacy, and patients in low-income households face the steepest barriers to eHealth tools. The gap is structural, not accidental. A systematic review on IoT in healthcare found that age, education level, and income consistently predict whether patients accept or reject connected health devices, with older and less-educated patients reporting the lowest acceptance rates across studies.
Older adults with dementia encounter a compounding problem: the cognitive impairment that makes remote monitoring most valuable also makes it hardest to use. A systematic review on mHealth and dementia found that most mobile health interventions during COVID-19 were designed without adequate input from this population, leaving caregivers to bridge a gap the tools weren’t built to close.
Cancer patients with lower education use digital health tools at significantly lower rates than their more-educated peers. A cross-sectional survey of cancer patients found that education level was one of the strongest predictors of ICT use during active treatment — meaning patients who may need the most support are least likely to access it digitally.
Gynecologic cancer survivors show a similar pattern. An observational study of the LETSGO mHealth app found that older age and lower baseline digital engagement predicted lower app use during follow-up care, even when the app was provided as part of routine treatment.
Low eHealth literacy cuts across demographics. A cross-sectional study using latent profile analysis identified distinct clusters of eHealth literacy, with lower-literacy profiles concentrated among older adults, people with less formal education, and those with limited prior technology use.
Patients in low-resource settings face a different barrier: infrastructure. A mixed-methods implementation study in Pakistan documented how unreliable connectivity and device scarcity undercut digital referral systems even when clinical staff were trained and willing to use them.
Cost rarely appears in telehealth marketing. Wearable monitors, connected devices, and app subscriptions carry price tags that compound existing inequities — a point the IoT acceptance review flags as a recurring barrier in the published literature. Patients who most need continuous monitoring are often the least able to afford the hardware that delivers it.
How are cancer patients actually using digital health tools during treatment?
Disclaimer: This section presents general health information for educational purposes only. It is not medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional before making any health decisions.
Cancer patients are adopting digital health tools—wearables, symptom-tracking apps, and connected devices—at measurable but uneven rates during active treatment. Usage breaks sharply along lines of age, education, and what the tools actually require patients to do. A cross-sectional survey of cancer patients receiving antineoplastic or supportive therapy found that ICT use varied significantly by treatment phase and patient profile, with younger, more educated patients reporting higher engagement.
The evidence reveals specific patterns:
Symptom tracking and communication dominate actual use. Patients most commonly used digital tools to communicate with care teams and track treatment-related symptoms. Educational content and appointment management—features platforms often market as primary draws—saw far lower adoption.
Age cuts usage sharply. Older patients in active treatment reported lower ICT use across nearly every category measured. This gap matters because older adults carry a disproportionate share of cancer diagnoses.
App engagement drops fast after enrollment. A study of the LETSGO mHealth app for gynecologic cancer survivors found that actual app usage declined over time, and that baseline factors including prior digital experience predicted who kept using it. Enrollment numbers tell patients nothing about sustained engagement.
Privacy and complexity drive abandonment. A systematic review on IoT usage in healthcare found that patient acceptance barriers consistently included data privacy concerns, technical complexity, and lack of integration with existing care workflows—problems that vendors rarely disclose upfront.
eHealth literacy is not evenly distributed. A cross-sectional study on eHealth literacy profiles found that sociodemographic factors—income, education, age—clustered into distinct literacy groups, meaning a tool designed for one group may be nearly inaccessible to another.
The gap between a platform’s marketing claims and what patients actually do with it during chemotherapy or radiation is wide. Patients should ask any digital health vendor for retention data—not just download or enrollment figures—and confirm whether the tool connects directly to their oncology team’s records or operates as a separate, siloed system.
Do patients trust wearable monitors enough to use them consistently?
Patient trust in wearable monitors — and broader IoT health adoption — is real but fragile, shaped less by technology skepticism than by concrete, solvable barriers like data privacy fears, poor usability, and uneven digital literacy. Trust exists; consistent use does not always follow.
A 2024 systematic review covering patient acceptance of connected health devices identified privacy and security concerns as the single most cited barrier to sustained use. Patients weren’t rejecting the concept of monitoring — they were rejecting the terms. Specifically, the review found that patients worried about who accesses their health data, how it is stored, and whether it could be shared with insurers or employers without their knowledge. Those are rational concerns, not technophobia.
Usability gaps compound the trust problem. The same review found that device complexity and poor interface design drove abandonment, particularly among older adults and patients with lower digital literacy. A cross-sectional study on eHealth literacy confirmed that sociodemographic factors — age, education level, and prior technology exposure — predict whether patients can engage with digital health tools at all. Patients who score low on eHealth literacy don’t distrust wearables; they simply can’t use them confidently enough to build a habit.
Condition-specific data reveals the deeper picture:
- A cross-sectional survey on wearable fetal heart monitors found that prospective users expressed strong interest in the technology but flagged anxiety about interpreting readings without immediate clinical guidance — a trust gap between the device and the care team, not the device itself.
- An observational study of a gynecologic cancer mHealth app found that consistent app use dropped off when patients felt the tool wasn’t integrated into their actual clinical follow-up. Patients used the app when providers acknowledged it. When providers ignored it, patients stopped.
- A survey of cancer patients receiving antineoplastic therapy found that ICT use varied sharply by age and education, with younger, more educated patients far more likely to engage with digital monitoring tools consistently.
The pattern across these studies points to one concrete conclusion: patients trust wearable monitors more when a real clinician is visibly on the other end. Devices marketed as standalone solutions — with no clear pathway to a provider who reviews the data — see the steepest drop-off. Patients aren’t passive. They’re making a reasonable calculation about whether the effort is worth it.
This section presents general health information for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before making decisions about your care.
Can AI-assisted screening and digital referral systems work in low-resource settings?
Disclaimer: This section presents general health system and technology information for educational purposes only. It is not medical advice, a diagnosis, or a treatment recommendation. Consult a qualified healthcare professional for personal health decisions.
AI-assisted screening and digital referral systems can work in low-resource settings, but the evidence shows they work unevenly — and the gap between a vendor’s pitch and a patient’s real experience is often wide. IoT health adoption faces documented barriers in under-resourced environments: unreliable internet, device costs, low digital literacy, and patient distrust of automated systems, all of which a systematic review found consistently limit uptake regardless of how well a platform performs in a controlled trial.
The most credible real-world example comes from Pakistan. A neurosurgery-led digital emergency referral system in Khyber Pakhtunkhwa — a province with severe specialist shortages — is currently being studied as a mixed-methods implementation project designed to move head-injury patients from district hospitals to neurosurgical care faster than paper-based referral chains allow, according to the published protocol. The system routes clinical data through a structured digital form, which a neurosurgeon reviews remotely. That is a narrow, well-defined use case. It is not a general AI diagnostic tool, and the researchers are explicit that implementation fidelity — whether staff actually use the system correctly under pressure — is an open question the study is still measuring.
AI screening for diabetic retinopathy offers a cleaner success story, but only under specific conditions. A roadmap published for Croatia’s national screening program found that AI-assisted grading can match specialist accuracy when image quality is controlled and when a trained human reviews flagged cases before any referral is made, per the Croatia telemedicine review. Remove either condition and accuracy drops. Low-resource clinics often struggle with both.
Digital literacy compounds every other barrier. A cross-sectional study found that eHealth literacy clusters strongly by age, education, and socioeconomic status — meaning the patients most likely to need low-cost digital screening are often the least equipped to navigate it, as the eHealth literacy study documents. Vendors rarely advertise this.
What patients navigating these systems should watch for:
- Validation location matters. A system validated in a high-income urban clinic may not perform the same way in a rural district hospital with older imaging equipment and intermittent connectivity.
- Human review is not optional. Any AI screening tool that routes patients to care without a qualified clinician reviewing the output before action is taken carries real risk.
- Referral speed is not the same as referral accuracy. A digital system can move a referral faster while still sending the wrong patient to the wrong level of care.
The Pakistan referral study is worth watching precisely because it is measuring implementation failure, not just success rates — a standard most commercial telehealth vendors do not apply to themselves.
What do these findings mean for regulators and health system administrators?
Regulators and health system administrators need to treat uneven IoT health adoption as a structural access problem, not a marketing gap — and the evidence demands policy responses that go beyond voluntary industry guidelines. Patients who cannot navigate connected health devices face measurable barriers that the market, left alone, has not resolved.
A systematic review of IoT usage in healthcare identified privacy concerns, poor device usability, and low digital literacy as the top barriers patients report — barriers that fall hardest on older adults, lower-income households, and people with limited formal education. Regulators who treat these as individual shortcomings rather than design and access failures will keep writing rules that protect no one.
Specific gaps demand specific responses:
-
Literacy stratification is real and measurable. A cross-sectional study on eHealth literacy found that sociodemographic factors — age, education, income — reliably predict who can read, evaluate, and act on digital health information. Administrators who design telehealth onboarding for a single “average user” are designing for a patient who doesn’t exist.
-
Acceptability data should precede deployment, not follow it. A survey on wearable fetal monitors showed that prospective users held significant concerns about device comfort and data security before they ever used the product. Health systems that skip pre-deployment acceptability testing are buying complaints, not solutions.
-
Cancer patients using digital tools follow distinct access patterns. A comparative survey of ICT use in cancer care found that patients receiving antineoplastic therapy used digital health tools at different rates depending on treatment type and setting — a finding that should push administrators to audit which patient populations their telehealth platforms actually reach.
-
National screening programs show what coordinated policy can do. Croatia’s diabetic retinopathy screening roadmap integrates telemedicine and AI within a nationally coordinated framework — a model that demonstrates how governments can set standards, fund infrastructure, and define accountability in ways that individual providers cannot.
The enforcement gap is the core problem. Agencies can publish guidance documents indefinitely; what moves the needle is mandatory interoperability standards, transparent pricing disclosure requirements, and audit mechanisms that check whether underserved populations are actually being reached. Administrators who wait for the market to self-correct on access equity will be waiting through the next decade of the same disparities.
This section presents general information for consumer awareness purposes and does not constitute medical advice, diagnosis, or treatment recommendations. Consult a qualified healthcare professional for guidance specific to your situation.
FAQ
What is IoT health adoption and why does it matter?
IoT health adoption refers to patients and clinicians integrating internet-connected devices—such as wearable monitors, remote sensors, and app-linked diagnostics—into routine care. A 2025 systematic review in JMIR mHealth and uHealth found that adoption rates vary sharply by population, making equity a central concern for health systems.
What barriers most commonly block patients from using IoT health devices?
The JMIR mHealth and uHealth systematic review (PMID 42544626) identified privacy concerns, perceived complexity, and low digital literacy as the top barriers. Cost and lack of clinician guidance also appeared repeatedly across the reviewed studies.
Which patient groups have the lowest eHealth literacy?
A cross-sectional study published in Frontiers in Public Health (PMID 42577340) used latent profile analysis to show that older adults, people with lower formal education, and lower-income individuals cluster into distinct low-literacy profiles. These groups are not a monolith, so interventions designed for one profile often miss another.
Are cancer patients using digital tools during treatment?
A comparative cross-sectional survey in the Journal of Medical Internet Research (PMID 42561404) found that use of information and communication technologies among cancer patients varied significantly by treatment type, age, and the level of institutional support offered. Availability of a tool did not reliably predict whether patients used it.
How acceptable are wearable fetal heart monitors to pregnant users?
A JMIR Formative Research survey (PMID 42575502) found that prospective users generally viewed a wearable fetal heart monitor positively, but raised concerns about physical comfort, skin sensitivity, and anxiety over interpreting the data themselves. These design and support gaps need to be addressed before broad rollout.
Can telemedicine screening programs work for diabetic retinopathy in countries without established systems?
A roadmap study published in Medicina (PMID 42512794) examined how Croatia could build a national diabetic retinopathy screening program by integrating European evidence, telemedicine infrastructure, and AI-assisted image analysis. The authors found that AI can extend screening reach, but only if grounded in a coordinated national policy framework.
Did mHealth tools help dementia patients during the COVID-19 pandemic?
A systematic review in Health Science Reports (PMID 42504235) found that mobile health interventions offered some benefit for dementia patients during pandemic-related isolation, particularly for caregiver support and remote monitoring. However, the review noted that most studies were small and methodologically limited, making firm conclusions difficult.
What does a digital emergency referral system in Pakistan reveal about implementation challenges?
A mixed-methods protocol from Khyber Pakhtunkhwa (PMID 42467936) shows that a neurosurgery-led digital referral system faces barriers rooted in clinician training, infrastructure reliability, and workflow integration rather than patient-facing technology. The study’s findings suggest that implementation science—not just engineering—determines whether such systems succeed.
This article is for general information and is not medical, legal, or financial advice. Telehealth services, prescriptions, and insurance coverage vary by state and provider — verify a provider’s licensing and consult a qualified professional before making care decisions.